IP Library Granted Patent US 12,667,564
Granted Patent B2
US 12,667,564 · App. 17/536,892 · Granted Jun 30, 2026

Processes for preparing morphinan-6-one products with low levels of α, β-unsaturated ketone compounds

Inventors: Henry J. Buehler (St. Louis, MO); William E. Dummitt (St. Louis, MO); Anthony Mannino (Maryland Heights, MO); Dennis C. Aubuchon (Arnold, MO); Hong Gu (Oak Park, CA)
Assignee: SpecGX LLC
A61K31/485C07D489/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,667,564
App. No.
17/536,892
Granted
Jun 30, 2026
Kind
B2
Abstract

The present invention generally relates to processes for preparing highly pure morphinan-6-one products. The processes involve reducing the concentration of alpha, beta unsaturated ketone compounds present as impurities in morphinan 6 one products or reaction mixtures including morphinan 6 one compounds by treatment with a sulfur-containing compound.

Claims (19)

1 . A process for preparing oxymorphone HCl having a reduced concentration of 14-hydroxymorphinone, comprising:

a. forming a reaction mixture comprising oxymorphone HCl and 14-hydroxymorphinone;

b. treating the reaction mixture with a non-thiol sulfur-containing compound to reduce the concentration of the 14-hydroxymorphinone in the reaction mixture; and

c. recovering oxymorphone base to produce the oxymorphone HCl.

2 . The process of claim 1 , wherein at least one of the following conditions are present:

(i) the molar ratio of non-thiol sulfur-containing compound to oxymorphone in the reaction mixture is from about 0.5:1 to about 3.0:1;

(ii) the reaction mixture is treated with the non-thiol sulfur-containing compound for at least about 1 hour;

(iii) the reaction mixture is treated with the non-thiol sulfur-containing compound at a temperature greater than room temperature; or

(iv) the oxymorphone is recovered from the reaction mixture without the use of an organic solvent.

3 . The process of claim 1 , wherein the non-thiol sulfur-containing compound is a sulfur-containing nucleophile.

4 . The process of claim 1 , wherein the non-thiol sulfur-containing compound is a sulfur-containing inorganic acid or salt thereof.

5 . The process of claim 1 , wherein the non-thiol sulfur-containing inorganic acid is selected from the group consisting of hydrosulfuric acid (H 2 S); sulfurous acid (H 2 SO 3 ); persulfuric acid (H 2 SO 5 ); thiosulfurous acid (H 2 S 2 O 2 ); dithionous acid (H 2 S 2 O 4 ); disulfurous acid (H 2 S 2 O 5 ); dithioic acid (H 2 S 2 O 6 ); pyrosulfuric acid (H 2 S 2 O 7 ); peroxydisulfuric acid (H 2 S 2 O 8 ); trithionic acid (H 2 S 3 O 6 ); tetrathionic acid (H 2 S 4 O 6 ); pentathionic acid (H 2 S 5 O 6 ); chlorosulfonic acid (HSO 3 Cl); furosulfonic acid (HSO 3 F); sulfamic acid (HSO 3 NH 2 ); salts thereof; and combinations thereof.

6 . The process of claim 4 , wherein the salt is selected from the group consisting of alkali metal salts, alkaline earth metal salts, ammonium salt (NH4+), and quaternary ammonium salts.

7 . The process of claim 1 , wherein the reaction mixture further comprises a media material.

8 . The process of claim 7 , wherein the weight ratio of media material to oxymorphone in the reaction mixture is from about 1:1 to about 50:1.

9 . The process of claim 7 , wherein the media material is an aqueous media or an aqueous/organic solvent biphasic media.

10 . The process of claim 9 , wherein the aqueous media is water.

11 . The process of claim 1 , wherein after recovery the oxymorphone HCl comprises less than 0.001% of 14-hydroxymorphinone as determined by HPLC with MS.

12 . The process of claim 1 , wherein after recovery the oxymorphone HCl comprises less than 0.0005% of 14-hydroxymorphinone as determined by HPLC with MS.